+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Biochemical changes associated with the antifungal action of the triazole ICI 153,066 on Candida albicans and Trichophyton quinckeanum



Biochemical changes associated with the antifungal action of the triazole ICI 153,066 on Candida albicans and Trichophyton quinckeanum



FEMS Microbiology Letters 79(2-3): 127-131



The triazole antifungal agent, ICI 153,066, acts on Candida albicans and Trichophyton quinckeanum by inhibiting demethylation of the sterol ring. In C. albicans this is at the level of lanosterol whereas in T. quinckeanum it is at the level of 24-methylene lanosterol. Inhibition of the demethylation system was shown to be non-competitive, the Vmax of the enzyme was reduced rather than affinity for the substrate lanosterol. The changes in the sterols of C. albicans lead to inhibition of the transport of amino acids into the yeasts which probably resulted from alterations in the membrane bound permeation systems. The reduction in uptake of amino acids was shown to reflect a change in the velocity of transport rather than the affinity of the amino acids for the transport systems.

(PDF emailed within 0-6 h: $19.90)

Accession: 002036468

Download citation: RISBibTeXText

PMID: 2060756

DOI: 10.1111/j.1574-6968.1991.tb04517.x


Related references

Selective inhibitory action of fluconazole, an antifungal agent of triazole-derivative, on sterol 14-C demethylation of Candida albicans cells. Japanese Journal of Medical Mycology 27(3): 190-197, 1986

In vitro and in vivo antifungal activities of FX0685, a novel triazole antifungal agent with potent activity against fluconazole-resistant Candida albicans. Medical Mycology 43(3): 227-233, 2005

Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes. Antimicrobial Agents and ChemoTherapy 27(5): 832-835, 1985

On the immumochemical and biochemical studies of fungi. XI. Cross reaction of the polysaccharides of Aspergillus fumigatus, Candida albicans, Saccharo-myces cerevisiae and Trichophyton rubrum against Candida albicans and Saccharomyces cerevisiae antisera. Jap. J. Microbiol, 11: 4, 269-273, 1967

On the problem of Trichophyton quinckeanum and of the term mouse favus. 1. Comparative study on 12 strains of Trichophyton quinckeanum on different culture media. Mykosen 11(5): 313-328, 1968

Cement dermatitis associated with an allergy to "Candida albicans" and of "Trichophyton". Treatment with extracts of "Candida albicans" and of "Trichophyton". Return to work. Final treatment with griseofulvin. Bulletin de la Societe Francaise de Dermatologie et de Syphiligraphie No 4: 458-460, 1959

Resistance of adhered cells of Candida albicans to the triazole antifungal fluconazole. Abstracts of the General Meeting of the American Society for Microbiology 97(0): 14, 1997

Calcofluor white combination antifungal treatments for Trichophyton rubrum and Candida albicans. Plos One 7(7): E39405-E39405, 2013

Differential antifungal effects of stereoisomeric styrylimidazole compounds on Candida albicans and Trichophyton rubrum. Japanese Journal of Medical Mycology 31(4): 363-368, 1990

In vitro studies of a new antifungal triazole, D0870, against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts. Antimicrobial Agents and ChemoTherapy 37(10): 2126-2131, 1993

D0870 a new triazole antifungal agent activity against candida albicans in experimental vaginal and systemic infections in mice. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 32: 285, 1992

Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae. Journal of General Microbiology 131(10): 2581-2589, 1985

Comparison of D0870, a new triazole antifungal agent, to fluconazole for inhibition of Candida albicans cytochrome P-450 by using in vitro assays. Antimicrobial Agents and ChemoTherapy 40(6): 1382-1386, 1996

Antifungal activity of 4-hydroxy-3-(3-methyl-2-butenyl)acetophenone against Candida albicans: evidence for the antifungal mode of action. Antonie van Leeuwenhoek 108(5): 1047-1057, 2016

Efficient click chemistry towards fatty acids containing 1,2,3-triazole: Design and synthesis as potential antifungal drugs for Candida albicans. European Journal of Medicinal Chemistry 136: 596-602, 2017